Rebif® Rebidose® Versus Rebiject II® Ease-of-Use

Clinical trial NCT02019550 · COMPLETED

Trial details

NCT number: NCT02019550
Sponsor: EMD Serono
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Multiple Sclerosis, Relapsing-Remitting

Start date: 2014-03-01
Primary completion: 2016-01-01
Enrollment: 97

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.